C Emi Bretschneider1, Kemi M Doll2, Jeannette T Bensen3, Paola A Gehrig2, Jennifer M Wu1, Elizabeth J Geller1. 1. 1 Division of Urogynecology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina. 2. 2 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina. 3. 3 Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Abstract
OBJECTIVES: Sexual health in survivors of gynecologic cancer has been studied; however, sexual health in these women before treatment has not been thoroughly evaluated. The objective of our study was to describe the pretreatment characteristics of sexual health of women with suspected gynecologic cancer before cancer treatment. MATERIALS AND METHODS: We performed a cross-sectional analysis of women with a suspected gynecologic cancer, who were prospectively enrolled in a hospital-based cancer survivorship cohort from August 2012 to June 2013. Subjects completed the validated Patient-Reported Outcomes Measurement Information System Sexual Function and Satisfaction Questionnaire. Pretreatment sexual health was assessed in terms of sexual interest, desire, lubrication, discomfort, orgasm, enjoyment, and satisfaction. RESULTS: Of 186 eligible women with suspected gynecologic cancer, 154 (82%) completed the questionnaire pretreatment. Mean age was 58.1 ± 13.3 years. Sexual health was poor: 68.3% reported no sexual activity, and 54.7% had no interest in sexual activity. When comparing our study population to the general U.S. population, the mean pretreatment scores for the subdomains of lubrication and vaginal discomfort were similar, while sexual interest was significantly lower and global satisfaction was higher. In a linear regression model, controlling for cancer site, age remained significantly associated with sexual function while cancer site did not. CONCLUSIONS: Problems with sexual health are prevalent in women with suspected gynecologic malignancies before cancer treatment. Increasing awareness of the importance of sexual health in this population will improve quality of life for these women.
OBJECTIVES: Sexual health in survivors of gynecologic cancer has been studied; however, sexual health in these women before treatment has not been thoroughly evaluated. The objective of our study was to describe the pretreatment characteristics of sexual health of women with suspected gynecologic cancer before cancer treatment. MATERIALS AND METHODS: We performed a cross-sectional analysis of women with a suspected gynecologic cancer, who were prospectively enrolled in a hospital-based cancer survivorship cohort from August 2012 to June 2013. Subjects completed the validated Patient-Reported Outcomes Measurement Information System Sexual Function and Satisfaction Questionnaire. Pretreatment sexual health was assessed in terms of sexual interest, desire, lubrication, discomfort, orgasm, enjoyment, and satisfaction. RESULTS: Of 186 eligible women with suspected gynecologic cancer, 154 (82%) completed the questionnaire pretreatment. Mean age was 58.1 ± 13.3 years. Sexual health was poor: 68.3% reported no sexual activity, and 54.7% had no interest in sexual activity. When comparing our study population to the general U.S. population, the mean pretreatment scores for the subdomains of lubrication and vaginal discomfort were similar, while sexual interest was significantly lower and global satisfaction was higher. In a linear regression model, controlling for cancer site, age remained significantly associated with sexual function while cancer site did not. CONCLUSIONS: Problems with sexual health are prevalent in women with suspected gynecologic malignancies before cancer treatment. Increasing awareness of the importance of sexual health in this population will improve quality of life for these women.
Entities:
Keywords:
gynecologic cancer; quality of life; sexual health
Authors: Ilana B Addis; Stephen K Van Den Eeden; Christina L Wassel-Fyr; Eric Vittinghoff; Jeanette S Brown; David H Thom Journal: Obstet Gynecol Date: 2006-04 Impact factor: 7.661
Authors: Kathryn E Flynn; Li Lin; Jill M Cyranowski; Bryce B Reeve; Jennifer Barsky Reese; Diana D Jeffery; Ashley Wilder Smith; Laura S Porter; Carrie B Dombeck; Deborah Watkins Bruner; Francis J Keefe; Kevin P Weinfurt Journal: J Sex Med Date: 2013-02 Impact factor: 3.802
Authors: Stacy Tessler Lindau; L Philip Schumm; Edward O Laumann; Wendy Levinson; Colm A O'Muircheartaigh; Linda J Waite Journal: N Engl J Med Date: 2007-08-23 Impact factor: 91.245